


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.24%
+4.17%
-0.85%
+4.03%
-6.27%
HUM
Humana
$262.00
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market
HUM Price Performance
$252.04 (+3.95%)
$278.72 (-6.00%)
$226.56 (+15.64%)
$239.85 (+9.23%)
HUM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

HUM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
HUM Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HUM Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is HUM current stock price?
What are HUM stock strengths?
What is HUM Risk Level?
What is HUM market cap and volume?
What is HUM current Stock IQ?
Should I buy HUM stock right now?
Is HUM a Strong Buy right now?
What does a 'Strong Buy' rating mean for HUM?
What does a 'Strong Sell' rating mean for HUM?
What factors influence HUM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.24%
+4.17%
-0.85%
+4.03%
-6.27%
HUM
Humana
Current Price
$262.00
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Outperform the market

HUM Price Performance
$252.04 (+3.95%)
$278.72 (-6.00%)
$226.56 (+15.64%)
$239.85 (+9.23%)
HUM Analysts Opinion
HUM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings decline YoY
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
HUM Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HUM Street Sentiment is extremely bullish and have positive views on the near-term outlook
HUM has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
HUM Stock IQ
HUM Latest Analysis
Humana Mark Cuban potentially teaming up for pharmacy partnership.
Thu Dec 4, 2025
HUM Quantitative Stock Analysis. Below is Valideas guru fundamental report for HUMANA INC (HUM). Of the 22 guru strategies we follow HUM rates highest using our Acquirers Multiple Investor model based on the published strategy of Tobias Carlisle. This deep value model looks for inexpensive stocks that could
Tue Nov 25, 2025
Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer. (Nasdaq: ) (Plus or the Company) announced today that it has signed a national agreement with Humana Inc. (NYSE: HUM) effective October 29 2025 covering approximately 16 million people throughout the United States to provide the CNSide® Cerebrospinal Fluid (CSF) Tumor Cell Enumeration (TCE) laboratory developed test (LDT). This brings CNSide CSF TCE LDT total policy
Thu Nov 20, 2025
Humana Inc. (HUM) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript.
Wed Nov 19, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.